Was the whole idea of this product to allow cheap 'home' treatment and free up very expensive hospital beds? The so called standard of care is still in a clinical setting , or hospital, so does it f:;king work at home or not? It may not heal quicker but surely if it saves lots of money for hospitals it has value? How much did the standard care cost per patient over the 12 weeks and how much did VL cost per patient?
- Forums
- ASX - By Stock
- DLM
- Ann: Results of Phase 2 Clinical Trial
Ann: Results of Phase 2 Clinical Trial, page-38
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online